FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/12/010788 [Registered on: 06/12/2017] Trial Registered Retrospectively
Last Modified On: 05/12/2017
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A trial to test the safety of a drug 
Scientific Title of Study   Phase 1 clinical trial for assessment of safety of a multi component botanical therapeutic (SKBDEVI) in healthy human volunteers 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ashok Kumar 
Designation  Chairman 
Affiliation  SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs) 
Address  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road, Aligarh

Aligarh
UTTAR PRADESH
202001
India 
Phone  8126688922  
Fax    
Email  ashok846@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ashok Kumar 
Designation  Chairman 
Affiliation  SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs) 
Address  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road, Aligarh


UTTAR PRADESH
202001
India 
Phone  8126688922  
Fax    
Email  ashok846@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ashok Kumar 
Designation  Chairman 
Affiliation  SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs) 
Address  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road, Aligarh


UTTAR PRADESH
202001
India 
Phone  8126688922  
Fax    
Email  ashok846@gmail.com  
 
Source of Monetary or Material Support  
SK Biolabs 15, Prayag Sarover, Ramghat Road, Aligarh-202001 (U.P.) India 
 
Primary Sponsor  
Name  SK Biolabs 
Address  15, Prayag Sarover, Ramghat Road, Aligarh-202001 (U.P.) India 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ashok Kumar  SK Biolabs  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road, Aligarh-202001
Aligarh
UTTAR PRADESH 
8126688922

ashok846@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SK Biolabs Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Human Volunteers 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  No comparator agent  Not applicable 
Intervention  SKBDEVI  Dose: 500 mgs capsule Frequency:Every 3-4 hours Route of administration: Oral Duration of therapy: 3-4 weeks 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Healthy Human Volunteers 
 
ExclusionCriteria 
Details  Patients suffering from any disease 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Any toxic side effects after oral intake of SKBDEVI such as fever, nausea, vomiting, headache, depression, irritation, anxiety, palpitation, choking, fainting, cough, skin rashes etc.  1 day 
 
Secondary Outcome  
Outcome  TimePoints 
Any toxic side effects after oral intake of SKBDEVI such as fever, nausea, vomiting, headache, depression, irritation, anxiety, palpitation, choking, fainting, cough, skin rashes etc.  4 weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "100"
Final Enrollment numbers achieved (India)="100" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/02/1999 
Date of Study Completion (India) 02/08/1999 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   No publication 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Multi component botanical therapeutic SKBDEVI causes no toxicity in healthy human volunteers except some volunteers reported mild constipation after 4 weeks. 
Close